Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) EV/EBITDA
As of 5 November 2026, Doximity, Inc. (DOCS) trades at a EV/EBITDA of 24.0×. Over the past ten years it has ranged from 11.1× (May 2026) to 159× (October 2021); the current reading is higher than 22% of that period. That is above the Health Information Services industry median of 13.4× and above the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2026 | 15.3× | (63.40%) |
| FY2025 | 41.9× | 74.98% |
| FY2024 | 24.0× | (34.82%) |
| FY2023 | 36.8× | (36.82%) |
| FY2022 | 58.2× | (16.90%) |
| FY2021 | 70.0× | 0.00% |
| FY2020 | 70.0× | 0.00% |
| FY2019 | 70.0× | — |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 19.9× | 40.39% |
| Jun 2026 | 14.2× | (7.42%) |
| Mar 2026 | 15.3× | (48.25%) |
| Dec 2025 | 29.7× | (40.12%) |
| 23 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| WAY Waystar Holding Corp. compare | 15.0× |
| HQY HealthEquity, Inc. compare | 18.2× |
| BTSG BrightSpring Health Services, Inc. compare | 21.9× |
| DOCS Doximity, Inc. | 24.0× |
| PRVA Privia Health Group, Inc. compare | 41.1× |
| HNGE Hinge Health Inc. compare | 54.5× |
| Health Information Services industry median | 13.4× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement